FOLLICULAR LYMPHOMA GRADE 3B

Clinical trials for FOLLICULAR LYMPHOMA GRADE 3B explained in plain language.

Never miss a new study

Get alerted when new FOLLICULAR LYMPHOMA GRADE 3B trials appear

Sign up with your email to follow new studies for FOLLICULAR LYMPHOMA GRADE 3B, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet recruiting 1 Not yet finished but already full! 1

New hope for lymphoma patients Who've run out of options

Disease control Ongoing

This early-stage study is testing whether adding a new immunotherapy drug called mosunetuzumab to standard chemotherapy is safe and effective for adults with aggressive B-cell lymphoma that has returned or not responded to prior treatment. The trial will enroll 24 participants to…

Matched conditions: FOLLICULAR LYMPHOMA GRADE 3B

Phase: PHASE1 • Sponsor: Washington University School of Medicine • Aim: Disease control

Last updated Mar 17, 2026 13:09 UTC

FOLLICULAR LYMPHOMA GRADE 3B

Get alerted when new FOLLICULAR LYMPHOMA GRADE 3B trials appear

New hope for lymphoma patients Who've run out of options